The number of Hispanics living with Alzheimer’s disease will soar over the next several decades at a rate far higher than the nation’s population as a whole, reports California Healthline. If no cure is found, cases of the disease across the entire U.S. are expected to triple by 2050, to 13.8 million, while among Hispanics, cases will increase eightfold, hitting 3.5 million by 2060, de Marco reports, citing research from the University of Southern California’s Edward R. Roybal Institute on Aging and Latinos Against Alzheimers. William Vega, one of the study’s authors, warns that “this is an incoming tsumani. If we don’t find a breakthrough medication, we are going to be facing a terrible financial crisis.” Experts blame a cultural aversion within the Hispanic community to acknowledge the disease and that families are often “in denial” that their loved ones are cognitively challenged.

Meanwhile, No Cure for Dementia in Sight as Rates Climb

Among nations with high-income economies, Alzheimer’s and other forms of dementia are now the third leading cause of death, behind heart disease and stroke, reports Bloomberg. Globally, dementia has surpassed HIV/AIDS as No. 7 among the World Health Organization’s 10 biggest causes of death. More than 100 experimental treatments have failed to slow the condition, the article notes, and progress toward an effective treatment is discouragingly slow. “I am less optimistic that I would like to be,” says Shekhar Saxena, director of WHO’s department of mental health and substance abuse, in the article.

Where the Jobs Are

If you’re looking for a new job, you may want to consider moving to Durham-Chapel Hill, N.C., where people are more likely to be employed in health care than they are in other cities. In an analysis by Abodo, 99.4 out of every 1,000 jobs in the region are in health care. The city far outranks its runners up: Birmingham-Hoover, Ala., (78.9), and Philadelphia, Pa. (78.1). This is likely because Durham-Chapel-Hill is located in the midst of three major universities: Duke, University of North Carolina and North Carolina State, accordng to Adobo. The metropolitan area also is home to UNC Health Care.

Baby Boxes Spur Safe Sleeping Practices

New Jersey has become the first state to adopt a program to reduce infant mortality by distributing portable, cardboard bassinets to parents of newborns, reports the New York Times. To receive the so-called baby boxes, parents must first take an online course about safe sleeping practices — putting infants to sleep on their backs on a firm mattress in a bassinet or crib, with no pillow, stuffed animals or bumpers. The boxes, which come with Pampers, baby wipes and more, are just a way to entice parents to get the education, said Kathie McCans, M.D., pediatric emergency physician at Cooper University Hospital and chair of the state’s Child Fatality and Near Fatality Review Board. “Honestly, people like free things,” she told the newspaper. In 2014, 93 percent of the state’s sudden unexpected infant death cases involved unsafe sleeping circumstances.

$89,000 for Emflaza Inflames Legislators

Kaiser Health News lays out the five reasons members of Congress are peeved that a drug to treat Duchenne muscular dystrophy was to go on the market for $89,000 a year. No. 1: Emflaza is the brand name for deflazacort, which has never been approved for sale in the U.S., but which some American Duchenne patients for years have imported from Europe and Canada for just $1,000 to $1,600 annually. To learn why else lawmakers are up in arms, read the KHN article here.